Literature DB >> 25232495

Activation of the Wnt pathway through Wnt2 promotes metastasis in pancreatic cancer.

Hua Jiang1, Qingqing Li1, Chengzhi He2, Fengru Li1, Haihui Sheng3, Xiaoying Shen3, Xiaoyan Zhang3, Shizhang Zhu3, Hui Chen3, Ximei Chen2, Changqing Yang2, Hengjun Gao4.   

Abstract

Wnt signaling pathway plays an important role in physiological and pathological process, including in the occurrence and development of tumor. The purpose of this study is to determine whether Wnt2 and sFRP4, key molecules of signaling pathway, are of prognostic value for survival in patients with pancreatic cancer. We performed immunohistochemistry on tissue microarrays containing 90 pancreatic cancer specimens to evaluate the protein expression of Wnt2 and sFRP4. Our results showed that the cytoplasmic expression level of Wnt2 in pancreatic cancer tissues was significantly associated with LNM (P=0.029) and AJCC stage (P=0.008). Additionally, Kaplan-Meier analysis indicated that high Wnt2 expression was significantly correlated with poor clinical outcomes of patients with pancreatic cancer. In conclusion, Wnt2 may play an important role in the development of pancreatic cancer through activation of the Wnt pathways and serve as a potential candidate for treatment target of pancreatic cancer.

Entities:  

Keywords:  Pancreatic cancer; Wnt signalling pathway; Wnt2; immunohistochemistry; sFRP4; survival analysis

Year:  2014        PMID: 25232495      PMCID: PMC4163618     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  27 in total

Review 1.  Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease.

Authors:  Paola Bovolenta; Pilar Esteve; Jose Maria Ruiz; Elsa Cisneros; Javier Lopez-Rios
Journal:  J Cell Sci       Date:  2008-03-15       Impact factor: 5.285

Review 2.  The WNT signaling pathway from ligand secretion to gene transcription: molecular mechanisms and pharmacological targets.

Authors:  Hoeke A Baarsma; Melanie Königshoff; Reinoud Gosens
Journal:  Pharmacol Ther       Date:  2013-01-14       Impact factor: 12.310

3.  Wnt2 as a new therapeutic target in malignant pleural mesothelioma.

Authors:  Julien Mazieres; Liang You; Biao He; Zhidong Xu; Sarah Twogood; Amie Y Lee; Noemi Reguart; Sonny Batra; Iwao Mikami; David M Jablons
Journal:  Int J Cancer       Date:  2005-11-01       Impact factor: 7.396

4.  Tissue microarrays in Chinese human rectal cancer: study of expressions of the tumor-associated genes.

Authors:  Mao Song Lin; Wei Chang Chen; Jun Xing Huang; Heng Jun Gao; Bao Feng Zhang; Jing Fang; Qiong Zhou; Ying Hu
Journal:  Hepatogastroenterology       Date:  2011 Nov-Dec

5.  Wnt proteins are lipid-modified and can act as stem cell growth factors.

Authors:  Karl Willert; Jeffrey D Brown; Esther Danenberg; Andrew W Duncan; Irving L Weissman; Tannishtha Reya; John R Yates; Roel Nusse
Journal:  Nature       Date:  2003-04-27       Impact factor: 49.962

Review 6.  The role of signaling pathways in the development and treatment of hepatocellular carcinoma.

Authors:  S Whittaker; R Marais; A X Zhu
Journal:  Oncogene       Date:  2010-07-19       Impact factor: 9.867

7.  Overexpression of Wnt-2 in colorectal cancers.

Authors:  J K Park; J H Song; T C He; S W Nam; J Y Lee; W S Park
Journal:  Neoplasma       Date:  2009       Impact factor: 2.575

8.  SFRP4 was overexpressed in colorectal carcinoma.

Authors:  Dan Huang; Bin Yu; Yun Deng; Weiqi Sheng; Zhilei Peng; Wenxin Qin; Xiang Du
Journal:  J Cancer Res Clin Oncol       Date:  2010-03       Impact factor: 4.553

9.  Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients.

Authors:  Francis Jacob; Kristjan Ukegjini; Sheri Nixdorf; Caroline E Ford; Jake Olivier; Rosmarie Caduff; James P Scurry; Rea Guertler; Daniela Hornung; Renato Mueller; Daniel A Fink; Neville F Hacker; Viola A Heinzelmann-Schwarz
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

10.  The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells.

Authors:  Caroline E Ford; Eve Jary; Sean Si Qian Ma; Sheri Nixdorf; Viola A Heinzelmann-Schwarz; Robyn L Ward
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

View more
  29 in total

1.  Wnt2 promotes non-small cell lung cancer progression by activating WNT/β-catenin pathway.

Authors:  Chongbiao Huang; Ruijue Ma; Yong Xu; Na Li; Zengxun Li; Jie Yue; Haixin Li; Yan Guo; Daliang Qi
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 2.  Pancreatic cancer stem cells.

Authors:  Ya-Yun Zhu; Zhou Yuan
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

3.  Decreased expression of USP9X is associated with poor prognosis in Chinese pancreatic ductal adenocarcinoma patients.

Authors:  Wei Liu; Yanmiao Huo; Jianyu Yang; Xueliang Fu; Minwei Yang; Lingye Tao; Dejun Liu; Junfeng Zhang; Rong Hua; Yongwei Sun
Journal:  Oncol Lett       Date:  2018-04-10       Impact factor: 2.967

4.  Role of RHOT1 on migration and proliferation of pancreatic cancer.

Authors:  Qingqing Li; Lei Yao; Youzhen Wei; Shasha Geng; Chengzhi He; Hua Jiang
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

5.  Decreased mRNA expression of transcription factor forkhead box F2 is an indicator of poor prognosis in patients with resected esophageal squamous cell carcinoma.

Authors:  Yu-Zhen Zheng; Jing Wen; Xun Cao; Hong Yang; Kong-Jia Luo; Qian-Wen Liu; Qing-Yuan Huang; Jun-Ying Chen; Jian-Hua Fu
Journal:  Mol Clin Oncol       Date:  2015-02-16

6.  Wnt2 protein plays a role in the progression of pancreatic cancer promoted by pancreatic stellate cells.

Authors:  Yong Xu; Hua Li; Chongbiao Huang; Tiansuo Zhao; Huan Zhang; Chen Zheng; He Ren; Jihui Hao
Journal:  Med Oncol       Date:  2015-03-03       Impact factor: 3.064

7.  The role of Dickkopf-1 as a potential prognostic marker in pancreatic ductal adenocarcinoma.

Authors:  De-Jun Liu; Yue-Xia Xie; Xiao-Xing Liu; Yan-Miao Huo; Min-Wei Yang; Xue-Liang Fu; Wei Liu; Jian-Yu Yang; Jiao Li; Rong Hua; Pei-Feng Liu; Yong-Wei Sun; Jun-Feng Zhang
Journal:  Cell Cycle       Date:  2017-07-27       Impact factor: 4.534

8.  The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma.

Authors:  Priya Pai; Satyanarayana Rachagani; Imayavaramban Lakshmanan; Muzafar A Macha; Yuri Sheinin; Lynette M Smith; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Mol Oncol       Date:  2015-10-19       Impact factor: 6.603

9.  The ubiquitin ligase RNF43 downregulation increases membrane expression of frizzled receptor in pancreatic ductal adenocarcinoma.

Authors:  Dadong Wang; Jingwang Tan; Yong Xu; Mingming Han; Yuliang Tu; Ziman Zhu; Chunqing Dou; Jin Xin; Xianglong Tan; Jian-Ping Zeng; Gang Zhao; Zhiwei Liu
Journal:  Tumour Biol       Date:  2015-08-05

Review 10.  Pancreatic cancer actionable genes in precision medicine and personalized surgery.

Authors:  Juehua Yu; Shi-He Liu; Robbi Sanchez; John Nemunaitis; Enrique Rozengurt; F Charles Brunicardi
Journal:  Surgeon       Date:  2016-06-28       Impact factor: 2.392

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.